Background: An intact hypothalami-pituitary-adrenal (HPA) axis with an effective intracellular anti-inflammatory activity of glucocorticoids is indispensable for host survival during stress upon exposure to an infectious agent. Community-acquired pneumonia (CAP) is characterized by significant mortality and increased circulating inflammatory cytokines. Despite adequate antimicrobial therapy mortality rates for CAP have not changed over several decades. The use of corticosteroids in patients with CAP is inconclusive. Study aim: To compare a 7 days treatment with prednisone and placebo in patients with community-acquired pneumonia with respect to time to clinical stability. Study hypothesis: The investigators hypothesize that use of corticosteroids will lead to a 25% relative risk reduction for death and clinical instability. Study type: randomized double blind intervention study Patients: 800 patients with community-acquired pneumonia
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Enrollment
800
50mg per day of prednisone orally for 7 days versus placebo
Medizinische Klinik, Kantonsspital Liestal
Liestal, Basel-Landschaft, Switzerland
Medicine Interne, Hôpital du Jura, site de Delémont
Delémont, Canton of Jura, Switzerland
Kantonsspital Aarau
Aarau, Switzerland
University Hospital Basel
Basel, Switzerland
Inselspital
Bern, Switzerland
Bruderholzspital
Bruderholz, Switzerland
Bürgerspital
Solothurn, Switzerland
Time to clinical stability
Time frame: 30 days
Side effects of corticosteroids, mortality, recurrence
Time frame: 30 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.